Search research articles
Contact Us
Filters
Showing results (1-10 of 101) with videos related to
Page
of 11
Sort By:
Multiple Sclerosis and Related Disorders
|
July 14, 2022
Satralizumab might not be enough. Olamkicept (sgp130Fc) in Neuromyelitis Optica Spectrum Disorder
Giuseppe Magro
Clinical Immunology (Orlando, Fla.)
|
July 7, 2022
Olamkicept(sgp130Fc): The missing trial in Neuromyelitis Optica Spectrum Disorder
Giuseppe Magro
Pediatric Neurology
|
June 4, 2025
Ket-Mid Study: Evidence for Early Combined Polytherapy in Prolonged Status Epilepticus (Stage 1 Plus) in Children
Giuseppe Magro
Medical Hypotheses
|
May 20, 2020
Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role
Giuseppe Magro
Epilepsia
|
June 18, 2026
Stage 1 Plus: A phenotype-based framework for rational polytherapy in status epilepticus
Giuseppe Magro
Virus Research
|
June 23, 2020
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
Giuseppe Magro
Neurology International
|
January 24, 2025
Early Polytherapy for Probably Benzodiazepine Refractory Naïve Status Epilepticus (Stage 1 Plus)
Giuseppe Magro
The American Journal of Medicine
|
August 3, 2025
Syncope: The oldest, yet the faintest tale - A call for a new definition
Giuseppe Magro
Epilepsia
|
March 2, 2026
Stage 1 Plus: Toward a unified operational framework in Status Epilepticus
Giuseppe Magro
Journal of Clinical Medicine
|
August 28, 2025
Beyond Seizures: A Comprehensive Review of Giant Somatosensory Evoked Potentials
Giuseppe Magro
Page
of 11
Search research articles
Search
Showing results (1-10 of 101) with videos related to
Sort By:
Page
of 11
Multiple Sclerosis and Related Disorders
|
July 14, 2022
Satralizumab might not be enough. Olamkicept (sgp130Fc) in Neuromyelitis Optica Spectrum Disorder
Giuseppe Magro
Clinical Immunology (Orlando, Fla.)
|
July 7, 2022
Olamkicept(sgp130Fc): The missing trial in Neuromyelitis Optica Spectrum Disorder
Giuseppe Magro
Pediatric Neurology
|
June 4, 2025
Ket-Mid Study: Evidence for Early Combined Polytherapy in Prolonged Status Epilepticus (Stage 1 Plus) in Children
Giuseppe Magro
Medical Hypotheses
|
May 20, 2020
Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role
Giuseppe Magro
Epilepsia
|
June 18, 2026
Stage 1 Plus: A phenotype-based framework for rational polytherapy in status epilepticus
Giuseppe Magro
Virus Research
|
June 23, 2020
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
Giuseppe Magro
Neurology International
|
January 24, 2025
Early Polytherapy for Probably Benzodiazepine Refractory Naïve Status Epilepticus (Stage 1 Plus)
Giuseppe Magro
The American Journal of Medicine
|
August 3, 2025
Syncope: The oldest, yet the faintest tale - A call for a new definition
Giuseppe Magro
Epilepsia
|
March 2, 2026
Stage 1 Plus: Toward a unified operational framework in Status Epilepticus
Giuseppe Magro
Journal of Clinical Medicine
|
August 28, 2025
Beyond Seizures: A Comprehensive Review of Giant Somatosensory Evoked Potentials
Giuseppe Magro
Page
of 11